Forum Review Mitochondrial Dysfunction: The First Domino in Brain Aging and Alzheimer's Disease?
暂无分享,去创建一个
Reham M. Abdel-Kader | A. Eckert | S. Hauptmann | I. Scherping | U. Keil | R. Abdel-Kader | K. Leuner | J. Strosznajder | W. Müller
[1] K. Maiese,et al. A “FOXO” in sight: Targeting Foxo proteins from conception to cancer , 2009, Medicinal research reviews.
[2] J. Birks,et al. Ginkgo biloba for cognitive impairment and dementia (Review) , 2017 .
[3] K. Jellinger,et al. Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort. , 2008, Journal of psychiatric research.
[4] M. Mattson,et al. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. , 2008, Journal of neurochemistry.
[5] K. Maiese,et al. Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies , 2008, Progress in Neurobiology.
[6] R. Sandhir,et al. Mitochondrial Oxidative Stress and Dysfunction in Rat Brain Induced by Carbofuran Exposure , 2008, Cellular and Molecular Neurobiology.
[7] Adolfas Toleikis,et al. Effect of Ginkgo biloba extract on the rat heart mitochondrial function. , 2007, Journal of ethnopharmacology.
[8] D. Butterfield,et al. An increase in S‐glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach , 2007, Journal of neuroscience research.
[9] W. Müller,et al. Ginkgo Biloba Extract (EGb 761) Independently Improves Changes in Passive Avoidance Learning and Brain Membrane Fluidity in the Aging Mouse , 1996, Pharmacopsychiatry.
[10] M. Lardelli,et al. Alzheimer disease: amyloidogenesis, the presenilins and animal models. , 2007, Biochimica et biophysica acta.
[11] W. Wätjen,et al. The Ginkgo biloba extract EGb761 reduces stress sensitivity, ROS accumulation and expression of catalase and glutathione S-transferase 4 in Caenorhabditis elegans. , 2007, Pharmacological research.
[12] A. Navarro,et al. The mitochondrial energy transduction system and the aging process. , 2007, American journal of physiology. Cell physiology.
[13] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[14] O. Napryeyenko,et al. Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features , 2007, Arzneimittelforschung.
[15] D. Butterfield,et al. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD , 2006, Neurobiology of Aging.
[16] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[17] D. Butterfield,et al. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. , 2006, Antioxidants & redox signaling.
[18] P. Bria,et al. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo‐controlled double‐blind study , 2006, European journal of neurology.
[19] C. Culmsee,et al. Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders. , 2006, Current Alzheimer research.
[20] W. Müller,et al. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease , 2006, Experimental Gerontology.
[21] Xiongwei Zhu,et al. Involvement of Oxidative Stress in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.
[22] Barry Halliwell,et al. Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.
[23] J. Quinn,et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.
[24] D. Allan Butterfield,et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease , 2006, Neurobiology of Disease.
[25] M. Mattson,et al. Ageing and neuronal vulnerability , 2006, Nature Reviews Neuroscience.
[26] P. Burnett,et al. Calcium oscillations in type-1 astrocytes, the effect of a presenilin 1 (PS1) mutation , 2006, Neuroscience Letters.
[27] W. Müller,et al. Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice. , 2006, Free radical biology & medicine.
[28] D. Butterfield,et al. Mutations in amyloid precursor protein and presenilin‐1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β‐peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease , 2006, Journal of neurochemistry.
[29] N. Bresolin,et al. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease , 2006, Neurobiology of Aging.
[30] W. Klein,et al. Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease , 2006, Journal of Biological Chemistry.
[31] Douglass M. Turnbull,et al. Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease? , 2006, Human Genetics.
[32] C. Dalmaz,et al. Aging affects oxidative state in hippocampus, hypothalamus and adrenal glands of Wistar rats. , 2005, Life sciences.
[33] X. Chen,et al. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease , 2005 .
[34] P. Doering,et al. Vitamin C and Vitamin E for Alzheimer's Disease , 2005, The Annals of pharmacotherapy.
[35] D. Wallace. A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.
[36] A. Navarro,et al. Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[37] Anne Eckert,et al. Stabilization of Mitochondrial Membrane Potential and Improvement of Neuronal Energy Metabolism by Ginkgo Biloba Extract EGb 761 , 2005, Annals of the New York Academy of Sciences.
[38] P. Axelsen,et al. Promotion of Oxidative Lipid Membrane Damage by Amyloid β Proteins , 2005 .
[39] J. Mazat,et al. Gradual Alteration of Mitochondrial Structure and Function by β-Amyloids: Importance of Membrane Viscosity Changes, Energy Deprivation, Reactive Oxygen Species Production, and Cytochrome c Release , 2005, Journal of bioenergetics and biomembranes.
[40] W. Ward,et al. Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[41] M. Emond,et al. Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria , 2005, Science.
[42] R. Ravid,et al. Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.
[43] L. Costa,et al. Effect of sustained hypobaric hypoxia during maturation and aging on rat myocardium. I. Mechanical activity. , 2005, Journal of applied physiology.
[44] F. Coppedè,et al. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients , 2005, Neurobiology of Aging.
[45] D. Praticò. Peripheral biomarkers of oxidative damage in Alzheimer's disease: the road ahead , 2005, Neurobiology of Aging.
[46] F. Schmitt,et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment , 2005, Neurology.
[47] C. Leeuwenburgh,et al. Age‐associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] Robert S. Balaban,et al. Mitochondria, Oxidants, and Aging , 2005, Cell.
[49] K. Maiese,et al. Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease , 2005, Progress in Neurobiology.
[50] T. Bayer,et al. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice , 2005, Neurobiology of Disease.
[51] P. Reddy,et al. Time‐course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging , 2005, Journal of neurochemistry.
[52] G. Perry,et al. β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways , 2005, Journal of neurochemistry.
[53] A. A. Starkov,et al. Mitochondrial metabolism of reactive oxygen species , 2005, Biochemistry (Moscow).
[54] C. Masters,et al. Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42 , 2005, The Journal of Neuroscience.
[55] M. Subathra,et al. Supplementation of L-carnitine Improves Mitochondrial Enzymes in Heart and Skeletal Muscle of Aged Rats , 2005, Experimental aging research.
[56] M. Nieto,et al. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice , 2004, Neuroscience.
[57] R. Weindruch,et al. Ageing, oxidative stress, and mitochondrial uncoupling. , 2004, Acta physiologica Scandinavica.
[58] C. Haass,et al. Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis* , 2004, Journal of Biological Chemistry.
[59] Ana Navarro,et al. Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[60] H. Luhmann,et al. Altered morphological and electrophysiological properties of Cajal–Retzius cells in cerebral cortex of embryonic Presenilin‐1 knockout mice , 2004, The European journal of neuroscience.
[61] F. Müller-Spahn,et al. Elevated nitric oxide production mediates beta-amyloid-induced mitochondria failure. , 2004, Polish Journal of Pharmacology.
[62] J. Gilbert,et al. Analysis of European mitochondrial haplogroups with Alzheimer disease risk , 2004, Neuroscience Letters.
[63] A. Woźniak,et al. Activity of antioxidant enzymes and concentration of lipid peroxidation products in selected tissues of mice of different ages, both healthy and melanoma-bearing , 2004, Zeitschrift für Gerontologie und Geriatrie.
[64] Thomas Wisniewski,et al. Amyloid‐β Deposition Is Associated with Decreased Hippocampal Glucose Metabolism and Spatial Memory Impairment in APP/PS1 Mice , 2004 .
[65] D. Butterfield,et al. Free radicals and brain aging. , 2004, Clinics in geriatric medicine.
[66] J. Birks. Is Ginkgo biloba Effective and Safe for Dementia and Cognitive Impairment? , 2004, Neuroepidemiology.
[67] Xi Chen,et al. Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .
[68] A. Navarro,et al. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[69] J. Growdon,et al. Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[70] C. Haass. Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation , 2004 .
[71] I. Santana,et al. Cytochrome c oxidase is decreased in Alzheimer’s disease platelets , 2004, Neurobiology of Aging.
[72] Cornelia I Bargmann,et al. Comparing genomic expression patterns across species identifies shared transcriptional profile in aging , 2004, Nature Genetics.
[73] T. Bayer,et al. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice , 2003, Experimental Neurology.
[74] P. Mecocci,et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease , 2003, Neurobiology of Aging.
[75] Charles L. Hoppel,et al. Production of Reactive Oxygen Species by Mitochondria , 2003, Journal of Biological Chemistry.
[76] J. Blass. Cerebrometabolic abnormalities in Alzheimer's disease , 2003, Neurological research.
[77] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[78] C. Haass,et al. Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation , 2003, Journal of Biological Chemistry.
[79] P. Bars. Magnitude of effect and special approach to Ginkgo biloba extract EGb 761 in cognitive disorders. , 2003 .
[80] S. Hofer,et al. Evaluating the interdependence of aging-related changes in visual and auditory acuity, balance, and cognitive functioning. , 2003, Psychology and aging.
[81] Michael S. Wolfe,et al. γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[82] G. Oxenkrug,et al. Mating Attenuates Aging‐Associated Increase of Lipid Peroxidation Activity in C57BL/6J Mice , 2003, Annals of the New York Academy of Sciences.
[83] D. Butterfield,et al. Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model , 2003, Neurobiology of Aging.
[84] M. Robin,et al. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells , 2003, The Journal of cell biology.
[85] T. Iwatsubo,et al. The role of presenilin cofactors in the γ-secretase complex , 2003, Nature.
[86] E. Mikhailova,et al. The Dynamics of Morphological Measures and Lipid Peroxidation during Aging of the Cerebral Cortex in Humans , 2003, Neuroscience and Behavioral Physiology.
[87] A. Murphy,et al. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. , 2002, The Biochemical journal.
[88] T. Fath,et al. Tau-Mediated Cytotoxicity in a Pseudohyperphosphorylation Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[89] D. Turnbull,et al. The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease , 2002, Neuropathology and applied neurobiology.
[90] Y. Christen,et al. What is Ginkgo biloba extract EGb 761? An overview--from molecular biology to clinical medicine. , 2002, Cellular and molecular biology.
[91] K. Hensley,et al. Oxidative stress in brain aging Implications for therapeutics of neurodegenerative diseases , 2002, Neurobiology of Aging.
[92] D. Butterfield,et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 , 2002, Journal of neurochemistry.
[93] Zhixin Wu,et al. Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans. , 2002, Cellular and molecular biology.
[94] G. Fiskum,et al. Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity. , 2002, Cellular and molecular biology.
[95] M. di Luca,et al. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease. , 2002, Cellular and molecular biology.
[96] D. Butterfield,et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. , 2002, Free radical biology & medicine.
[97] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[98] C. Haass,et al. Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer’s APP mutation and sensitizes cells to staurosporine-induced cell death , 2002, Journal of Molecular Neuroscience.
[99] J. Tower,et al. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. , 2002, Genetics.
[100] L. Packer,et al. Bioflavonoid‐Rich Botanical Extracts Show Antioxidant and Gene Regulatory Activity , 2002, Annals of the New York Academy of Sciences.
[101] M. Vitek,et al. Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[102] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[103] S. Rapoport,et al. Ginkgo biloba Extracts EGb 761 and Bilobalide Increase NADH Dehydrogenase mRNA Level and Mitochondrial Respiratory Control Ratio in PC12 Cells , 2002, Neurochemical Research.
[104] Ana Navarro,et al. Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[105] M. Kim,et al. Age-related changes in the distribution of nitrotyrosine in the cerebral cortex and hippocampus of rats , 2002, Brain Research.
[106] David W. Killilea,et al. Age-associated mitochondrial oxidative decay: Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-l- carnitine and/or R-α-lipoic acid , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[107] M. Mattson,et al. Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. , 2002, Physiological reviews.
[108] J. Land,et al. β‐Amyloid inhibits integrated mitochondrial respiration and key enzyme activities , 2001, Journal of neurochemistry.
[109] P. Riederer,et al. Anti‐inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia , 2001, The European journal of neuroscience.
[110] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[111] A. Henriques,et al. The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats , 2001, Phytotherapy research : PTR.
[112] Michael J. Rowan,et al. Amyloid-β oligomers: their production, toxicity and therapeutic inhibition , 2001 .
[113] A. Nunomura,et al. Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.
[114] F Gonzalez-Lima,et al. Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration , 2001, The Journal of Neuroscience.
[115] Virginia M. Y. Lee,et al. Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis , 2001, The Journal of Neuroscience.
[116] P. Schultz,et al. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[117] F. Gonzalez-Lima,et al. Effects of Chronic Sodium Azide on Brain and Muscle Cytochrome Oxidase Activity: A Potential Model to Investigate Environmental Contributions to Neurodegenerative Diseases , 2001, Journal of toxicology and environmental health. Part A.
[118] C. Haass,et al. Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation , 2001, Journal of neuroscience research.
[119] G. Kim,et al. Oxidative Stress and Neuronal DNA Fragmentation Mediate Age-Dependent Vulnerability to the Mitochondrial Toxin, 3-Nitropropionic Acid, in the Mouse Striatum , 2001, Neurobiology of Disease.
[120] V. Agin,et al. Effects of learning on cytochrome oxidase activity in cuttlefish brain , 2001, Neuroreport.
[121] V. Papadopoulos,et al. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands , 2001, Brain Research.
[122] R. Nitsch,et al. Tau Filament Formation in Transgenic Mice Expressing P301L Tau* , 2001, The Journal of Biological Chemistry.
[123] U. Beisiegel,et al. Resistance of human cerebrospinal fluid to in vitro oxidation is directly related to its amyloid-β content , 2001, Free radical research.
[124] S. Hoyer. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update , 2000, Experimental Gerontology.
[125] H. Ku,et al. Age-associated changes of superoxide dismutase and catalase activities in the rat brain. , 2000, Journal of biomedical science.
[126] A. Nunomura,et al. Oxidative damage in Alzheimer’s disease: the metabolic dimension , 2000, International Journal of Developmental Neuroscience.
[127] F. V. Defeudis,et al. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.
[128] C. Michiels,et al. Protection by bilobalide of the ischaemia‐induced alterations of the mitochondrial respiratory activity , 2000, Fundamental & clinical pharmacology.
[129] A. Nunomura,et al. Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.
[130] K. Davis,et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. , 2000, JAMA.
[131] C. Colton,et al. Microglial Contribution to Oxidative Stress in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.
[132] O. Pansarasa,et al. Age-dependent changes of antioxidant activities and markers of free radical damage in human skeletal muscle. , 1999, Free radical biology & medicine.
[133] L. Lue,et al. Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .
[134] H. Chung,et al. Regional difference of ROS generation, lipid peroxidaton, and antioxidant enzyme activity in rat brain and their dietary modulation , 1999, Archives of pharmacal research.
[135] N. Hay,et al. Mutant Presenilin-1 Induces Apoptosis and Downregulates Akt/PKB , 1999, The Journal of Neuroscience.
[136] Haruhisa Inoue,et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation , 1999, Nature Medicine.
[137] H. C. Lee,et al. Concurrent increase of oxidative DNA damage and lipid peroxidation together with mitochondrial DNA mutation in human lung tissues during aging--smoking enhances oxidative stress on the aged tissues. , 1999, Archives of biochemistry and biophysics.
[138] G. Cortopassi,et al. Mitochondria in organismal aging and degeneration. , 1999, Biochimica et biophysica acta.
[139] R. S. Sohal,et al. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[140] D. Butterfield,et al. The expression of key oxidative stress-handling genes in different brain regions in alzheimer’s disease , 1998, Journal of Molecular Neuroscience.
[141] F. Terro,et al. Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures , 1998, Neuroscience.
[142] M. Mattson,et al. Increased Sensitivity to Mitochondrial Toxin-Induced Apoptosis in Neural Cells Expressing Mutant Presenilin-1 Is Linked to Perturbed Calcium Homeostasis and Enhanced Oxyradical Production , 1998, The Journal of Neuroscience.
[143] L. Tian,et al. Alterations of antioxidant enzymes and oxidative damage to macromolecules in different organs of rats during aging. , 1998, Free radical biology & medicine.
[144] M. Tabaton,et al. Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.
[145] J. Palacino,et al. Regulation of Apoptosis by Presenilin 1 , 1998, Neurobiology of Aging.
[146] J. Sastre,et al. A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress. , 1998, Free radical biology & medicine.
[147] A. Schatzberg,et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. , 1997, JAMA.
[148] Turan M. Itil,et al. A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia , 1997 .
[149] R. Davis,et al. Cybrids in Alzheimer's disease: A cellular model of the disease? , 1997, Neurology.
[150] M. Mattson,et al. Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.
[151] F. Gonzalez-Lima,et al. Regional brain effects of sodium azide treatment on cytochrome oxidase activity: a quantitative histochemical study , 1995, Metabolic Brain Disease.
[152] J. Kuo,et al. Effect of ageing on human plasma glutathione concentrations as determined by high-performance liquid chromatography with fluorimetric detection. , 1995, Journal of chromatography. B, Biomedical applications.
[153] D. Butterfield,et al. Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.
[154] J. Rommens,et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.
[155] J. Andersen,et al. Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain , 1995, Mechanisms of Ageing and Development.
[156] J. Zweier,et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide , 1995, Nature Medicine.
[157] P. Chagnon,et al. Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. , 1995, Neuroreport.
[158] M. Beal,et al. Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease , 1994, Journal of neurochemistry.
[159] B. Ames,et al. Oxidative damage and mitochondrial decay in aging. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[160] M. Mattson,et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[161] J. Miquel,et al. Age-related changes in glutathione and lipid peroxide content in mouse synaptic mitochondria: Relationship to cytochrome c oxidase decline , 1994, Neuroscience Letters.
[162] J. Coyle,et al. Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.
[163] J. Nobrega,et al. Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.
[164] O. Pastoris,et al. The mitochondrial electron transfer alteration as a factor involved in the brain aging , 1992, Neurobiology of Aging.
[165] R. Floyd,et al. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[166] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[167] V. Ravindranath,et al. Low glutathione levels in brain regions of aged rats , 1989, Neuroscience Letters.
[168] B. Ames,et al. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[169] D. Harman. Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.
[170] P. Reddy,et al. Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease , 2007, NeuroMolecular Medicine.
[171] S. Schaffer,et al. Plant foods and brain aging: a critical appraisal. , 2006, Forum of nutrition.
[172] A. Eckert,et al. Mitochondrial dysfunction induced by disease relevant AbetaPP and tau protein mutations. , 2006, Journal of Alzheimer's disease : JAD.
[173] D. Selkoe,et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.
[174] Yuan Luo,et al. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. , 2003, Journal of Alzheimer's disease : JAD.
[175] J. Blass,et al. The role of the metabolic lesion in Alzheimer's disease. , 2002, Journal of Alzheimer's disease : JAD.
[176] Yuan Luo. Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease. , 2001, Journal of Alzheimer's disease : JAD.
[177] S. Leutner,et al. Age-related increase of oxidative stress-induced apoptosis in micePrevention by Ginkgo biloba extract (EGb761) , 2001, Journal of Neural Transmission.
[178] F. Lopera,et al. Ultrastructure evidence of necrotic neural cell death in familial Alzheimer's disease brains bearing presenilin-1 E280A mutation. , 2001, Journal of Alzheimer's disease : JAD.
[179] S. Leutner,et al. ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain , 2001, Journal of Neural Transmission.
[180] B. Ames,et al. Part X • Chapter 27 – Oxidants and aging , 2000 .
[181] L. Packer,et al. Mitochondrial dysfunction in the senescence accelerated mouse (SAM). , 1998, Free radical biology & medicine.
[182] T. Hamilton,et al. The cell biology of macrophage activation. , 1984, Annual review of immunology.